Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mediascan59on Nov 30, 2010 3:24pm
255 Views
Post# 17778566

RE: RE: Something to consider

RE: RE: Something to considerSTCKGUY,
Show me the post where I told you I rode epo and ppi up for  two months. As per efg, I first entered it at .30 and although I do not recall  the price when I mentioned it here being .36...but I will take it that  it is accurate, I believe it  went to .44 after that, and  since then found out why it was  sold off at that time.
As per tax loss selling, I didn't respond to you because  first of all  I didn't feel I needed too, and second, because I felt that most  were....are in a profit position  with  this play above .30, so there is not  "tax selling" to take advantage of with efg...and that was....is very obvious to me.
Next?...
Bullboard Posts